Drug Free Solution, Inc.
DSOL
Rank in Stocks
#33793
Based in El Segundo, California, Drug Free Solution, Inc. operates as a... Based in El Segundo, California, Drug Free Solution, Inc. operates as a lifestyle enterprise focused on emotional well-being. The company offers its proprietary "Living Breath Process," an innovative, three-stage technique that integrates self-reflection, guided breathing, and specific linguistic patterns. This method is designed to cater to various needs, including addiction prevention and recovery, personal growth, emotional health, and overall lifestyle enhancement. Beyond its core process, Drug Free Solution, Inc. also provides the "Living Breath Series" of programs, which bundles related products, educational resources, and supportive services. A significant arm of the company's mission is the "Living Breath Project." This initiative leverages distinct protocols, lifestyle-enhancing products, and comprehensive training and education to foster the establishment of community wellness centers, dedicated wellness residences, and essential support networks within correctional facilities. The overarching goal of these efforts is to significantly reduce addiction and incarceration rates across the United States. Known as Living Breath Project, Inc. until its renaming in January 2014, the company subsequently adopted its present corporate identity.
Share Price
$0.0004
Last synced: 2026-11-10
Market Cap
$177.78K
Change (1 day)
0.00%
Change (1 year)
-63.64%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Drug Free Solution, Inc. (DSOL)
Category
Healthcare
EPS for Drug Free Solution, Inc. (DSOL)
EPS as of August 2024 TTM: 0.00
According to Drug Free Solution, Inc.'s latest financial reports, its current EPS (TTM) is 0.00. At the end of 2025 the company had an EPS of 0.00, equal to its 2024 EPS of 0.00.
EPS history for Drug Free Solution, Inc. from 2013 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | 0.00% |
| 2025 | 0.00 | 0.00% |
| 2024 | 0.00 | -100.00% |
| 2023 | 0.00 | -96.97% |
| 2020 | 0.00 | -44.07% |
| 2019 | $-0.01 | 55.26% |
| 2018 | 0.00 | 171.43% |
| 2017 | 0.00 | -99.98% |
| 2013 | $-8.93 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $3.86 | - |
US
|
|
| $1.64 | - |
US
|
|
| $1.79 | - |
AU
|
|
| $-1.05 | - |
US
|
|
| $2.08 | - |
US
|
Questions about Drug Free Solution, Inc.'s earnings per share (EPS)
What was Drug Free Solution, Inc.'s earnings per share (EPS) in 2025?
In 2025, Drug Free Solution, Inc.'s earnings per share (EPS) was 0.00, compared with 0.00 in 2024.
How has Drug Free Solution, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Drug Free Solution, Inc.'s earnings per share (EPS) was highest in 2025 (0.00) and lowest in 2025 (0.00).
How does Drug Free Solution, Inc.'s earnings per share (EPS) compare with similar companies?
Drug Free Solution, Inc.'s earnings per share (EPS) (0.00) is higher than that of 1 of the 5 similar companies listed above. The highest among them is GE HealthCare Technologies Inc., with $3.86.